Pharmacotherapy Management of COPD Exacerbation (PCE)

Assesses chronic obstructive pulmonary disease (COPD) exacerbations for adults 40 years of age and older who had appropriate medication therapy to manage an exacerbation. A COPD exacerbation is defined as an inpatient or ED visit with a primary discharge diagnosis of COPD.

Why it Matters

Approximately 15 million adults in the United States have COPD, an irreversible disease that limits airflow to the lungs. COPD exacerbations or “flare-ups” make up a significant portion of the costs associated with the disease.¹ However, symptoms can be controlled with appropriate medication.²,³ Appropriate prescribing of medication following exacerbation can prevent future flare-ups and drastically reduce the costs of COPD.

Results

USE OF SYSTEMIC CORTICOSTEROIDS
CommercialMedicaidMedicare
YearHMOPPOHMOHMOPPO
201776.175.068.270.470.6
201670.569.165.967.568.6
201575.972.667.171.974.6
201475.472.965.371.872.5
201375.572.865.870.671.6
201273.570.865.469.169.8
201171.369.564.166.868.8
201069.866.265.366.669.6
200966.164.161.860.964.2
200867.058.261.760.060.8
USE OF BRONCHODILATORS
CommercialMedicaidMedicare
YearHMOPPOHMOHMOPPO
201780.579.781.480.676.2
201676.675.080.678.974.1
201580.178.280.081.177.0
201480.777.679.080.977.6
201380.178.780.980.776.9
201280.877.781.580.476.8
201179.976.880.478.475.9
201077.873.582.178.276.1
200978.075.080.776.274.9
200876.168.178.274.171.3

References

  1. Pasquale, M.K., S.X. Sun, F. Song, H.J. Hartnett, and S.A. Stemkowski. “Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.” International Journal of COPD 7:757-64. doi: 10.2147/COPD.S36997.
  2. National Heart, Lung, and Blood Institute. 2012. “Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases.”
  3. Global Initiative for Chronic Obstructive Lung Disease. 2014. “Global Strategy for the Diagnosis, and Prevention of Chronic Obstructive Pulmonary Disease.”

  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.